Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional Registry
NCT07800247 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-09-02
Summary
This is a retrospective descriptive study to create an institutional registry that will continue as a prospective follow-up non-intervention study that will be carried out at Hematology Oncology and BMT Department, Children's Hospital, Ain-Shams University, Cairo, Egypt.
Conditions
- Sickle Cell Disease (SCD)
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Eligibility
- Max Age
- 39 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-17
- Primary Completion
- 2027-01-01
- Completion
- 2027-03-01
Countries
- Egypt
Study Locations
More Related Trials
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis.
NCT05993065 ·Status: UNKNOWN
-
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
NCT00736060 ·Status: COMPLETED
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA
-
The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease
NCT06158945 ·Status: RECRUITING
-
Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"
NCT06735625 ·Status: RECRUITING ·Phase: NA
-
Hydroxyurea in the Treatment of Sickle Cell Disease
NCT02709681 ·Status: COMPLETED
-
Study of Hydroxyurea to Treat Sickle Cell Disease
NCT02868138 ·Status: COMPLETED
-
Exploring Adherence Monitoring in Sickle Cell Disease
NCT03708731 ·Status: ACTIVE_NOT_RECRUITING
-
Folic Acid Supplementation as an Appetizer in Primary Malnourished Egyptian Infants and Children
NCT03040219 ·Status: UNKNOWN ·Phase: PHASE4
-
Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease Jamaica
NCT05909657 ·Status: UNKNOWN
-
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
NCT03049475 ·Status: COMPLETED
-
Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease
NCT07200869 ·Status: NOT_YET_RECRUITING
-
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)
NCT00000586 ·Status: COMPLETED ·Phase: PHASE3
-
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
NCT01905787 ·Status: UNKNOWN
-
Genetic and Haematological Modifiers of SCD Severity in Kaduna State, Northern Nigeria
NCT05837871 ·Status: UNKNOWN
-
Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease
NCT00143572 ·Status: COMPLETED ·Phase: PHASE1
-
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
NCT02371720 ·Status: COMPLETED ·Phase: NA
-
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea
NCT00480974 ·Status: COMPLETED
-
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
NCT00305175 ·Status: COMPLETED
-
Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
NCT04667325 ·Status: COMPLETED
-
Transfusion Treatment in Patients With SCD
NCT03397017 ·Status: COMPLETED
-
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus
NCT03851055 ·Status: COMPLETED ·Phase: PHASE3
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring
NCT06464458 ·Status: RECRUITING ·Phase: NA